Stephen G. Worthley

Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study

Sondergaard L, Walton AS, Worthley SG, Smith D, Chehab B, Manoharan G, Yong G, Bedogni F, Bates N, Reardon M

March 9, 2023 | 10.4244/EIJ-D-22-01108

Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial

Worthley SG, Redwood S, Hildick-Smith D, Rafter T, Whelan A, De Marco F, Horrigan M, Delacroix S, Gregson J, Erglis A

January 20, 2021 | 10.4244/EIJ-D-20-00484

Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system

Gooley R, Worthley SG, Whitbourn R, Montarello J, Newcomb A, Allocco D, Meredith I

December 7, 2018 | 10.4244/EIJ-D-18-00664

Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study

Maisano F, Worthley SG, Rodés-Cabau J, Linke A, Fichtlscherer S, Schäfer U, Makkar R, Fontana G, Asch F, Søndergaard L

October 19, 2018 | 10.4244/EIJ-D-18-00343

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel AM, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley SG, Tchetche D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchetche D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchetche D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley SG, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Aortic atheroma burden predicts acute cerebrovascular events after transcatheter aortic valve implantation: insights from volumetric multislice computed tomography analysis

Kataoka Y, Puri R, Pisaniello A, Hammadah M, Qintar M, Uno K, Montarello J, Nicholls S, Worthley SG

August 20, 2016 | 10.4244/EIJV12I6A127

Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach

Tzikas A, Gafoor S, Meerkin D, Freixa X, Cruz-González I, Lewalter T, Saw J, Berti S, Nielsen-Kudsk J, Ibrahim R, Lakkireddy D, Paul V, Arzamendi D, Nietlispach F, Worthley SG, Hildick-Smith D, Thambo J-B, Tondo C, Aminian A, Kalarus Z, Schmidt B, Søndergaard L, Kefer J, Meier B, Park J, Sievert H, Omran H

April 20, 2016 | 10.4244/EIJV11I13A292

Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease

Puri R, Leong D, Nicholls S, Liew G, Nelson A, Carbone A, Copus B, Wong D, Beltrame J, Worthley SG, Worthley M

April 20, 2015 | 10.4244/EIJV10I12A249

A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial

Sakata K, Koo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley SG, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P

March 20, 2015 | 10.4244/EIJY14M08_16

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study

Meredith I, Worthley SG, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco D, Dawkins K

March 20, 2014 | 10.4244/EIJV9I11A216

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley SG, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky A, Bichalska M, Meis S, Verheye S

September 27, 2013 | 10.4244/EIJV9I5A93

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning AP, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis S, Gao R, Holmes D, Jeong M, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll H, Worthley SG, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

First-in-human experience with the Medtronic Bifurcation Stent System

Meredith I, Worthley SG, Whitbourn R, Webster M, Fitzgerald P, Ormiston J

October 28, 2011 | 10.4244/EIJV7I6A108

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

Meredith I, Worthley SG, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins G, Hendriks R, Matsis P, Muller D, Cutlip D

January 15, 2010

The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial

Meredith I, Worthley SG, Whitbourn R, Walters D, Popma J, Cutlip D, Fitzgerald P

May 22, 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley SG, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Stephen G. Worthley

Latest news